-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $26

Benzinga·05/16/2025 17:17:14
Listen to the news
B. Riley Securities analyst Madison El-Saadi reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $24 to $26.